CD38 monoclonal antibodies target the CD38 surface antigen(sAg) of hematopoietic cells, which is important for cell function. Once CD38 monoclonal antibodies bind to the antigen it inhibits tumour growth by interrupting CD38 functions and causes cell death. CD38 monoclonal antibodies are used to treat multiple myeloma.
This report contains market size and forecasts of CD38 Monoclonal Antibodies in Global, including the following market information:
Global CD38 Monoclonal Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global CD38 Monoclonal Antibodies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Daratumumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CD38 Monoclonal Antibodies include Johnson & Johnson, Sanofi, Janssen Biotech, Carbosynth, Creative Biolabs and BOC Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CD38 Monoclonal Antibodies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CD38 Monoclonal Antibodies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global CD38 Monoclonal Antibodies Market Segment Percentages, by Type, 2021 (%)
Daratumumab
Isatuximab
Global CD38 Monoclonal Antibodies Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global CD38 Monoclonal Antibodies Market Segment Percentages, by Application, 2021 (%)
Pharmacy
Laboratory Use
Global CD38 Monoclonal Antibodies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global CD38 Monoclonal Antibodies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CD38 Monoclonal Antibodies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies CD38 Monoclonal Antibodies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Sanofi
Janssen Biotech
Carbosynth
Creative Biolabs
BOC Sciences